The chain of responsibility for decision-making and administration is diagrammed in Fig. 7: The Principal Investigator of the MTCC, R.C. Boucher, will be assisted in all activities by the Co-Directors, R.J. Samulski, P. Monahan, and J. Olsen. All Projects and Cores will report directly to the Principal Investigator and Co-Directors. The Principal Investigator and Co-Directors will be advised on a yearly basis by an External Advisory Board. In deference to the competitive review process, the three new members of the External Advisory Board for the next cycle will not be announced now. We project that the advisors will be experts in gene transfer vectors, cell biology of target epithelia, and translational research. The Principal Investigator and Co-Directors will also be advised on Program progress and direction on a twice-yearly basis by an Internal Advisory Committee (hereafter defined as the """"""""Governance Committee""""""""). The Internal Advisory Committee consists of the following individuals from UNC: 1) Dr. Rudolph Juliano, Professor of Pharmacology and Pharmacy, an expert in nanotechnology;2) Dr. Beverly Koller, Department of Genetics, an expert on mouse models of disease;and 3) Dr. Xiao Xiao, Professor of Pharmacy, and an expert in gene transfer vectors. The primary role of the Advisory Committees will be to monitor the scientific progress and quality of each Pilot and Feasibility (P&F) project, and the interrelationship between Cores and the activities of the UNC-CH gene transfer community. Any major programmatic changes, or changes in leadership, if replacement of the Director or a Co-Director becomes necessary, will be decided by these committees in consultation with the NIDDK staff.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Chapel Hill
United States
Zip Code
Sesma, Juliana I; Weitzer, Clarissa D; Livraghi-Butrico, Alessandra et al. (2016) UDP-glucose promotes neutrophil recruitment in the lung. Purinergic Signal 12:627-635
Mitchel, Jennifer A; Antoniak, Silvio; Lee, Joo-Hyeon et al. (2016) IL-13 Augments Compressive Stress-Induced Tissue Factor Expression in Human Airway Epithelial Cells. Am J Respir Cell Mol Biol 54:524-31
Livraghi-Butrico, A; Grubb, B R; Wilkinson, K J et al. (2016) Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease. Mucosal Immunol :
Button, Brian; Anderson, Wayne H; Boucher, Richard C (2016) Mucus Hyperconcentration as a Unifying Aspect of the Chronic Bronchitic Phenotype. Ann Am Thorac Soc 13 Suppl 2:S156-62
Cholon, Deborah M; Esther Jr, Charles R; Gentzsch, Martina (2016) Efficacy of lumacaftor-ivacaftor for the treatment of cystic fibrosis patients homozygous for the F508del-CFTR mutation. Expert Rev Precis Med Drug Dev 1:235-243
Yu, Dongfang; Davis, Richard M; Aita, Megumi et al. (2016) Characterization of Rat Meibomian Gland Ion and Fluid Transport. Invest Ophthalmol Vis Sci 57:2328-43
Dang, Hong; Gallins, Paul J; Pace, Rhonda G et al. (2016) Novel variation at chr11p13 associated with cystic fibrosis lung disease severity. Hum Genome Var 3:16020
Menachery, Vineet D; Yount Jr, Boyd L; Sims, Amy C et al. (2016) SARS-like WIV1-CoV poised for human emergence. Proc Natl Acad Sci U S A 113:3048-53
Watson, Michael J; Lee, Shernita L; Marklew, Abigail J et al. (2016) The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Uses its C-Terminus to Regulate the A2B Adenosine Receptor. Sci Rep 6:27390
Blackmon, Richard L; Kreda, Silvia M; Sears, Patrick R et al. (2016) Diffusion-sensitive optical coherence tomography for real-time monitoring of mucus thinning treatments. Proc SPIE Int Soc Opt Eng 9697:

Showing the most recent 10 out of 92 publications